What Is Clinical Risk Assessment?

Risk assessment in medicine is the conscientious evaluation of all relevant factors that help the clinician predict an adverse event or outcome. In psychiatry, risk assessment primarily — though not exclusively — concerns the prediction of suicide and serious self-harm in a given social circumstance. It also includes the assessment of risk to others (aggression, violence, and harm to identified third parties).

The prediction of suicide at a specified point in time, even after years of training and experience in this field, is extremely difficult. This is due to the large number of variables and their complex relationships, which are at play at any given time. How these varied factors influence an individual who ultimately takes their own life is unique to that individual. Furthermore, from an innate psychological perspective, deliberate self-destruction is contrary to the survival instinct.

There are well-researched and painstakingly evaluated published studies that have highlighted specific factors which should alert all clinicians to the possibility of an adverse outcome. However, prediction based only on the presence or absence of risk factors has a very low sensitivity and specificity. No risk assessment tool can reliably predict who will and who will not die by suicide. What is useful is an understanding of what circumstances are likely to lead to increased risk, and how that risk can be minimised through active, collaborative management.

Risk assessment for suicide requires the clinician's willingness to conduct a detailed assessment of physical and mental health; financial circumstances; the social context in which particular behaviours have arisen; and an understanding of effective and ineffective interventions in the past. A risk assessment is only useful if it leads to a better and agreed management plan among all concerned individuals and professionals. Above all, faithful implementation of the agreed plan is the essential step for safe, appropriate, and effective care.

Key Risk Factors for Suicide

The following are the key factors that should alert a clinician to a probable suicide attempt. These are divided into static risk factors (which do not change) and dynamic risk factors (which are modifiable):

Demographic and Static Factors

  • Male gender (men are approximately three times more likely to die by suicide than women in the UK, although women make more attempts)
  • Single, widowed, or divorced status
  • Older age in men; younger age in women
  • Social isolation
  • History of previous attempted self-harm (the single strongest predictor of future suicide)
  • History of alcohol or drug misuse and dependence with physical complications and loss of social status
  • Impulsive or aggressive personality traits

Clinical and Dynamic Factors

  • Presence of suicidal intent or ideation — active plans for suicide are of greater concern than passive ideation ("I wish I was dead")
  • Recent adverse life events: loss of employment, partner, or financial security; loss of family or community role
  • Pervasive feelings of hopelessness — often a stronger predictor than the severity of depression alone
  • Depressive illness and other psychiatric disorders with ongoing relapsing patterns, particularly psychotic depression
  • Presence of physical illness and chronic pain
  • Recent discharge from psychiatric hospital (the first two weeks after discharge carry significantly elevated risk)
  • Religious, spiritual, or personal belief system about life and death (can be protective or, in some circumstances, a risk factor)

The Process of Risk Evaluation

The following are essential steps in conducting a thorough risk assessment:

  1. The doctor should set aside enough time to complete the assessment in a sympathetic and unhurried fashion. The clinical environment should be private and as calm as possible.
  2. It is always useful to invite another health professional to join you — a community nurse or a senior ward nurse who knows the patient well and has been involved in their clinical management is very helpful, both for safety and to provide additional clinical information.
  3. It is also important to invite a member of the patient's family, with the patient's consent, to join you or to interview them separately after the initial patient interview.
  4. Conduct a systematic review of the patient's personal history — particularly recent losses (financial, relationship, social status) and their significance from the patient's perspective.
  5. Review the relevant past medical, psychiatric, and family history.
  6. Assess the current medical and mental health issues, the prescribed treatment, and the patient's perception of their prognosis.
  7. Conduct a detailed evaluation of depressive symptoms, attitude towards life, feelings of being a burden to others, guilt, and thoughts of suicidal intent.
  8. Differentiate clearly between passive suicidal ideation ("I wish I was dead") and active plans for self-harm or suicide (specific method, intent, and plan).
  9. Ask about religious, spiritual, or personal beliefs about life and death. Many patients with extreme hardship and very little left to live for will not consider suicide because of strongly held personal beliefs — these are protective factors and should be recognised and documented.
  10. Enquire about other protective factors. Almost all patients, except those with severe psychotic depression or other psychotic disorders, will acknowledge some reasons to continue living. Identifying and reinforcing these is a valuable component of management.
  11. Speak to other relevant health professionals — with the patient's consent — who have known the patient in the past, including the GP and community nursing staff.
  12. Consider completing a validated suicide risk scale. The Columbia Suicide Severity Rating Scale (C-SSRS) is now widely recommended in NHS settings for structured assessment of suicidal ideation and behaviour. The Beck Suicide Intent Scale (Beck, 1974) and Pierce's Modified Objective Intent Scale (BJP, 1977) are also used to translate the seriousness of a recent suicide attempt into a numerical format. However, no scale replaces a thorough clinical assessment — a very high or very low score does not always predict the ultimate outcome.

Limits of Risk Assessment

  1. It is not possible to identify and eliminate risk entirely.
  2. Risk fluctuates from day to day and sometimes from hour to hour; therefore, prediction is more accurate in the short term and even then is never one hundred percent accurate.
  3. The clinician will often not have access to all the essential facts at the time of assessment.
  4. A good risk assessment depends on reliable information from the patient and other informants — family, friends, colleagues. If the patient provides a misleading account, even the most thorough assessment may underestimate the risk.
  5. A comprehensive assessment of risk should incorporate the views of all relevant health professionals currently and previously involved in the patient's care, including the GP, hospital specialists, senior nursing staff, clinical psychologists, community nursing staff, and — where relevant — information from police and courts.

These limitations underline why risk assessment is a clinical process, not a predictive algorithm. The goal is not to achieve certainty — which is impossible — but to gather as much relevant information as possible, to reason carefully about it, and to make a defensible, well-documented clinical decision about management.

Formulation and Management of Risk

Once the assessment is complete, the risk should be formally formulated — summarised and categorised — as follows:

  1. Summarise the relevant personal details: age, gender, marital history, and past medical and psychiatric history.
  2. Identify the current stress factors and how they differ from previous circumstances. Note the precipitating factors of the current clinical state, including:
    • Recent bereavement
    • Recent relationship breakdown
    • Recent discharge from hospital or change in legal status
    • Anniversaries or reminders of the deaths of loved ones
    • Recent loss or threat of loss of employment
    • Financial loss or reputational damage
    • Threat of criminal charges or imprisonment
    • Unwanted pregnancy or peer suicide (particularly in adolescence)
  3. Classify the patient into a risk category to guide management planning and help minimise the risk of an adverse event.

Risk Categories

Category 1: Minimum Risk of Future Adverse Event

Key factors:

  1. First episode of deliberate self-harm with no evidence of:
    • Mental disorder
    • Continuing suicidal ideation or intent
    • History of drug or alcohol misuse
  2. Evidence that the triggering crisis has been resolved
  3. Presence of one or more of the following protective factors:
    • Strong social support network
    • Supportive partner, parents, or others
    • Stable personality
    • Optimistic outlook; positive religious, spiritual, or personal belief system
    • Sense of responsibility towards parents, children, or others
    • Willingness to receive medical and other help

Category 2: Moderate Risk of Future Adverse Event

Key factors:

  • Evidence of psychiatric disorder (depression, schizophrenia, or significant personality difficulties)
  • Presence of depressive delusions, ideas of reference, or command hallucinations in other psychotic disorders
  • Alcohol or drug misuse
  • Previous history of self-harm
  • Chronic physical health problems
  • Active suicidal ideation
  • Limited protective factors

Category 3: Severe (Serious) Risk of Future Adverse Event

Key factors:

  • All factors listed in Category 2
  • Plus a recent serious suicide attempt using a high-lethality method:
    • Gunshot wound
    • Attempted hanging
    • Carbon monoxide poisoning
    • Jumping from a height or in front of a vehicle
  • Active suicidal ideation with plans for a further attempt
  • Poor response to prescribed treatment for mental and physical health disorders
  • Presence of chronic pain
  • Absence of almost all protective factors

Conclusion: Clinical Decisions Following Risk Assessment

Once the assessment has been completed, all risk factors evaluated, understood, and documented, the following decisions must be made:

  1. Can the patient be safely discharged from hospital and treated in the community?
  2. Should the patient be admitted or transferred to a psychiatric inpatient unit?
  3. Who else needs to be involved to complete the risk assessment?
  4. When, where, and by whom will the risk assessment be reviewed?

The management of the suicidal patient and deliberate self-harm, and consent for treatment, are dealt with in Clinical Risk Assessment in Psychiatry – Part 2.

Frequently Asked Questions

Should I ask every patient about suicidal thoughts?

Yes. There is a persistent but unfounded clinical myth that asking about suicide will "plant the idea" in a patient's mind. The evidence does not support this. In fact, several studies (including RCTs) have shown that asking about suicidal thoughts is safe and can be experienced by patients as caring and therapeutic. Asking directly and sensitively — "Have you had any thoughts of harming yourself or ending your life?" — is an essential part of every psychiatric assessment and should also be performed in any general medical or emergency setting where mental health concerns are raised. Failure to ask, and to document the response, constitutes a significant clinical and medicolegal risk.

What is the difference between suicidal ideation, intent, and plan?

Suicidal ideation refers to thoughts of suicide or self-harm, which can range from passive ("I wish I was dead") to active ("I want to kill myself"). Suicidal intent refers to the degree to which the person actually intends to act on these thoughts — a patient with high intent has a firm decision to die, while a patient with low intent may have ideation without a clear resolve to act. A plan refers to a specific method the person has considered or prepared. The presence of a plan (especially a realistic, lethal, and available method) with high intent is associated with substantially elevated risk and should prompt urgent action. Document all three dimensions — ideation, intent, and plan — in every risk assessment.

What are protective factors in suicide risk assessment and why do they matter?

Protective factors are aspects of a patient's life, relationships, or belief system that reduce the likelihood of suicidal behaviour even in the presence of significant risk factors. They include: reasons for living (children, responsibilities to others); social connectedness and social support; access to mental health care; help-seeking behaviour; religious or personal beliefs against suicide; engagement with treatment; and future-oriented thinking. Identifying protective factors is not merely about "counting" them — it is about understanding which ones are genuinely meaningful to this particular patient. Protective factors should be actively reinforced in the management plan, not merely listed.

What is hopelessness and why is it particularly important in suicide risk?

Hopelessness — the pervasive belief that the future holds nothing good, that nothing will improve, and that one's situation is permanent and unchangeable — is one of the strongest clinical predictors of suicide risk, often more strongly predictive than the severity of depression alone. Aaron Beck's research demonstrated that hopelessness mediated the relationship between depression and suicidal intent. In clinical practice, assessing hopelessness is therefore essential: "Do you feel that things could get better? Do you feel there's any future for you?" The Beck Hopelessness Scale (BHS) provides a validated quantitative measure. Addressing hopelessness directly — through both pharmacological and psychological treatment — is a key target in suicide prevention.

What actuarial risk tools are used in psychiatry and what are their limitations?

The most widely used structured risk assessment tools include: the Columbia Suicide Severity Rating Scale (C-SSRS) for suicidal ideation and behaviour; the Beck Suicide Intent Scale for rating the seriousness of a recent suicide attempt; the Historical Clinical Risk Management-20 (HCR-20) for violence risk; the Psychopathy Checklist-Revised (PCL-R) for psychopathy in forensic settings; and the Suicide Assessment Five-step Evaluation and Triage (SAFE-T). All actuarial tools share important limitations: they were developed on specific populations and may not generalise; they measure group-level risk, not individual-level certainty; and a high or low score does not determine whether a particular person will or will not harm themselves or others. Tools should supplement — never replace — clinical judgement and a thorough individualised assessment.

How should I document a risk assessment in the clinical notes?

Documentation should be clear, contemporaneous, and sufficient for another clinician to understand the basis for the clinical decisions made. It should include: the sources of information used (patient, family, previous notes, GP); the risk factors identified (static and dynamic); the protective factors identified; the patient's mental state at the time of assessment; the risk category assigned; the management plan agreed and with whom; and the follow-up arrangements. Crucially, the reasoning behind the management decision should be explicit — not simply "moderate risk — refer to CMHT," but "moderate risk due to active suicidal ideation, previous self-harm, and limited social support; resolved to manage in community rather than admit because the precipitating crisis has partially resolved and the patient has agreed a safety plan with family support." Good documentation protects both the patient and the clinician.

For an ST3 interview — how would you assess and manage a patient presenting to A&E following an overdose?

A model answer covers: Step 1 — ensure medical safety (stabilise the patient; contact the National Poison Centre if needed). Step 2 — gather collateral history from family and review medical/psychiatric notes. Step 3 — arrange bloods, ECG, and toxicology screen. Step 4 — take a focused psychiatric history and MSE. Step 5 — complete a formal risk assessment covering suicidal ideation, intent, and plan; previous self-harm; psychiatric diagnosis; social stressors; and protective factors. Step 6 — classify the risk (minimum, moderate, or severe) and make a management decision accordingly. Document all of this clearly. Demonstrate knowledge of when to involve the crisis team versus when to admit to a psychiatric ward, and show awareness of consent and capacity principles in the context of a patient who may want to leave against advice.

References

  1. Gelder M, Harrison P, Cowen P. Shorter Oxford Textbook of Psychiatry (6th ed). Oxford University Press, 2010.
  2. Semple D, Smyth R. Oxford Handbook of Psychiatry (4th ed). Oxford University Press, 2019.
  3. NICE. Self-harm in over 8s: Short-term Management and Prevention of Recurrence (CG16). NICE, 2004.
  4. NICE. Self-harm: Assessment, Management and Preventing Recurrence (NG225). NICE, 2022.
  5. Beck AT, et al. Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalised with suicidal ideation. American Journal of Psychiatry. 1985;142(5):559–563.
  6. Posner K, et al. The Columbia Suicide Severity Rating Scale: Initial validity and internal consistency findings from three multisite studies with adolescents and adults. American Journal of Psychiatry. 2011;168(12):1266–1277.
  7. Ministry of Health New Zealand. Guidelines for Clinical Risk Assessment and Management in Mental Health Services. 1998.
  8. Royal Australian and New Zealand College of Psychiatrists. Guidelines for the Management of Deliberate Self-Harm in Young People. June 2000.
  9. National Confidential Inquiry into Suicide and Safety in Mental Health (NCISH). Annual Report, 2023. University of Manchester.